Testimonial from Dr. Domitille Gras on our innovative IVD test METAglut™ during World Health Day 2022
April 7, 2022
EIC Accelerator Funding awarded to drive innovation and next-level growth
November 19, 2022
September 21-24, 2022.
[EVENTS] Company ; METAflow
We were proud to showcase METAflow at our booth during the ESCCA (European Society for Clinical Cell Analysis) conference 2022, happening in Belfast.
This prestigious event brings together experts from across Europe to share the latest advancements in clinical data analysis and cytometry. It serves as a vital platform for networking, knowledge exchange, and exploring innovative technologies that enhance the field.
In the realm of scientific research, the ability to analyze multidimensional cytometry data is crucial. As the complexity of data continues to grow, there is an urgent need for innovative analytical tools that maintain data integrity. This is where METAflow steps in, offering a transformative solution for researchers and clinicians alike.
METAflow is designed with user experience in mind, featuring an intuitive interface that simplifies data analysis. This accessibility ensures that users—from seasoned researchers to newcomers—can effectively explore their data and achieve robust results.
What sets METAflow apart is its versatility. Tailored for both research and clinical applications in development, it empowers users across various fields to harness the power of multidimensional data. By providing a platform that respects data integrity, METAflow facilitates meaningful insights that can drive scientific discovery and improve patient outcomes.
At ESCCA 2022, we engaged with attendees, demonstrating how METAflow can revolutionize their approach to data analysis. The feedback we received reaffirmed our belief in the potential of our platform to make a significant impact in both research and clinical settings.
About the event organizer
ESCCA (European Society for Clinical Cell Analysis) is a scientific society founded to ensure the continuation of the activities of the European Working Group on Clinical Cell Analysis (EWGCCA).
EWGCCA was formed in 1996 with a Biomed-2 grant in order to establish collaboration between sixteen European centres that use and develop flow cytometric applications mainly for clinical purposes.
The ESCCA meetings are of major importance for education and scientific exchange in the fields of basic, translational and clinical applications in cytometry, in particular flow cytometry applications and in Hematology, Immunology, Cancer and Cell Biology.
As we continue to refine and enhance METAflow, we invite you to stay tuned for more updates and developments that will shape the future of multidimensional data analysis. Together, we are paving the way for a more accessible and effective approach to understanding complex datasets.
Showasing METAflow at the meeting of ESCCA 2022 has invigorated our commitment to advancing research and innovation in complex cytometry data analysis. We are dedicated to collaborating with experts and stakeholders to bring the best technology on the market!
